| | 
 |  |
Manufacturing:
DX Pharma has cGMP through multi product, multi-purpose facilities with reactors ranging from 500 to 6,000 gallons with supporting solids handling and refining equipment.
| Unit Processes:
 | |  Multi-step synthesis
Nitrile chemistry
Diels alder reactions
Maleic anhydride chemistry
Epichlorohydrin chemistry
| Glycidol chemistry
Epoxidation reactions
Hydrogenation
Distillation
| Analytical:
Fully staffed and operational 24 hours/day, 365 days/year
HPLC, GLPC, Mass spec, DSC, FTIR, Titrators
Method development and validation
| Regulatory/Quality Assurance:
cGMP emphasis for intermediates and API's
FDA inspection in 1998 with no 483's, and a FDA inspection in 2001 with no significant findings
Kosher and ISO 9000 certified
Quality and safety awards include Nalco-Stars, Kodak-Bronze, Osi-Superior Quality Award, and CMA-Lamont DuPont Safety Award
Primary waste treatment is centrally located on the site | | |
DX Pharma, Inc., 300 Jackson Hill, Houston, TX 77007
